In Diabetics with Ischemic Heart Disease CABG revascularization is always superior? Dr. Paolo Ferrazzi.

Slides:

Advertisements

Similar presentations

MAIN-COMPARE Study Stents versus Coronary-Artery Bypass Grafting for Left Main Coronary Artery Disease.

Advertisements

Is this the “spioenkop” for CABG?

Professor Abdus Samad MD FACC Karachi Institute of Heart Diseases Karachi, Pakistan May 1, 2010.

Cardiology Morning Report: Revascularization in Stable Ischemic Heart Disease Bobby Mathew, MD LSU Internal Medicine, HO-II.

Coronary Revascularisation in Patients With Diabetes Mellitus Dr Rod Stables The Cardiothoracic Centre Liverpool UK.

CARDIAC SURGERY QUESTION #1 Studies comparing CABG vs PTCA have shown that: A) CABG is better B) PTCA is better C) CABG involves more perioperative risk.

CABG GUIDELINES SANJAY DRAVID, M.D.. INTRODUCTION ACC/AHA GUIDELINE UPDATE FOR CORONARY ARTERY BYPASS GRAFT SURGERY (JACC 2004; 44: AND CIRCULATION.

Ischemic heart disease. Indications and methods of surgical treatment. Surgery department №2.

Published in Circulation 2005 Percutaneous Coronary Intervention Versus Conservative Therapy in Nonacute Coronary Artery Disease: A Meta-Analysis Demosthenes.

New ESC/EACTS guidelines on myocardial revascularisation Indications for coronary artery bypass grafting (CABG) vs. percutaneous coronary intervention.

New guidelines for CABG

SCAAR UCR SWEDEN 2007 Stefan James, Jörg Carlsson, Johan Lindbäck, Tage Nilsson, Ulf Stenestrand, Lars Wallentin and Bo Lagerqvist for the SCAAR study.

Coronary Artery Disease in Diabetic Patients, Different from Non-diabetics?

Stent or Surgery: What is Best for a Woman ? Dr R H Stables Cardiothoracic Centre Liverpool UK.

André Lamy Population Health Research Institute Hamilton Health Sciences McMaster University Hamilton, CANADA on behalf of the CORONARY Investigators Disclosures.

André Lamy Population Health Research Institute Hamilton Health Sciences McMaster University Hamilton, CANADA on behalf of the CORONARY Investigators Disclosures.

Richard Melsheimer Director, Medical Affairs Europe Centocor Eli Lilly and Company Coordinated Use of ReoPro and Drug Eluting Stents: Rationale and Evidence.

Arterial Revascularization Therapies Part II: a non- randomized comparison of contemporary PCI and coronary artery bypass grafting (CABG) in patients with.

Disclosures The presenter has no financial involvement with the product or competing products being discussed. The presenter received travel and lodging.

Jie Qian National Heart Center & FuWai Hospitall FFR in Diffuse Multivessel Disease.

The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.

Left Main Trifurcation Disease: Early and Long-Term Outcomes Of Percutaneous Coronary Intervention I.Sheiban, A.Gerasimou, F. Sciuto, P.Omedè, G. Biondi.

Left Main Stem Intervention Trials & Registries Keith D. Dawkins MD FRCP FACC Southampton University Hospital UK.

David Hildick-Smith Sussex Cardiac Centre. Background to ARTS Previous POBA studies Meta-analysis 3300 patients 1660 CABG, 1710 PTCA Deaths 79 PCI vs.

LONG-TERM OUTCOMES OF PERCUTANEOUS CORONARY INTERVENTION FOR UNPROTECTED LEFT MAIN CORONARY ARTERY DISEASE: INITIAL CLINICAL EXPERIENCE. Graidis Ch. 1,

Is the Decision-Making after Failure of CTO Angioplasty Same? Infarct Related CTO or Non- Infarct Related CTO (Continue the Procedure in Other Vessel or.

FRagmin® and Fast Revascularization during InStablity in Coronary artery disease FRISC II.

Are we doing enough PCI in the elderly ? Rosie Swallow Dorset Heart Centre Royal Bournemouth Hospital.

Multivessel Coronary Artery Disease

Samuel Thomas Rayburn, III MD Cardiovascular Surgeon Jack Stephens Heart Institute April 25, 2015.

Multivessel PCI in an Era of Freedom and FAME Michael J. Cowley, MD, FSCAI Nothing to Disclose.

Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Survival of patients with diabetes and multivessel.

J Am Coll Cardiol 2008;51:538–45 Acute and Late Outcomes of Unprotected Left Main Stenting in Comparison With Surgical Revascularization Pawel E. Buszman,

CABG IN DIABETICS DR. SEYED SAEED FARZAM. Introduction Patients with diabetes mellitus Increased incidence of CAD More extensive disease at angiography.

Date of download: 7/10/2016 Copyright © The American College of Cardiology. All rights reserved. From: Risk of Stroke With Coronary Artery Bypass Graft.

Prof. Dr. Sigmund Silber, FESC, FACC On behalf of the RESOLUTE

Revascularization Strategy: Syntax Score and Beyond

S Ten Tse and Sensibility!

ISCHEMIC HEART DISEASE

Single IMA {Single Arterial}

From: Systematic Review: The Comparative Effectiveness of Percutaneous Coronary Interventions and Coronary Artery Bypass Graft Surgery Ann Intern Med.

Harvard Clinical Research Institute, Boston, US

HYBRID CORONARY REVASCULARIZATION: IS THE NEW WAY TO GO

Final Five-Year Follow-up of the SYNTAX Trial: Optimal Revascularization Strategy in Patients With Three-Vessel Disease and/or Left Main Disease Patrick.

The MASS-DAC Study.

Figure 1 A flow chart describing the systematic process followed for article selection. From: A systematic review of cost-effectiveness of percutaneous.

CABG in diabetics: surgical aspects

Damian Gimpel Waikato Cardiothoracic Unit Journal Club

Robert A. Guyton, MD The Annals of Thoracic Surgery

Debate: What Does the Future Hold for the Treatment of Unprotected Left Main Disease? More PCI No More Routine Surgery Ron Waksman, MD, FACC Washington.

Percutaneous coronary invervention versus coronary artery bypass grafting: A meta- analysis Yolba Smit, MD, MSc, Joan Vlayen, MD, Hetty Koppenaal, MD,

Robert A. Guyton, MD The Annals of Thoracic Surgery

Diabetes mellitus in patients undergoing percutaneous drug-eluting stent implantation: short and long-term results Claudio Moretti, M.D. Division of Cardiology,

Giuseppe Biondi Zoccai, MD

The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.

(p = 0.32 for noninferiority)

Satya Shanbhag Waikato Cardiothoracic Unit

Does arterial revascularization decrease the risk of infarction after coronary artery bypass grafting? Paul T Sergeant, MD, PhD, Eugene H Blackstone,

Hisato Takagi, MD, PhD, Hideaki Manabe, MD, Takuya Umemoto, MD, PhD

The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.

Long-term outcome of revascularization with composite T-grafts: Is bilateral mammary grafting better than single mammary and radial artery grafting?

Impact of Diabetes Mellitus on Long-term Outcomes in the

To bypass or stent? The changing rules of an advancing game

IVUS-XPL Trial design: Patients undergoing drug-eluting stent implantation for long coronary lesions were randomized to IVUS-guided PCI (n = 700) vs. angiography-guided.

Cox regression of proportion mortality in the first 8 years for patients with three-vessel disease with a significant difference between the treatment.

NOBLE Trial design: Patients with unprotected left main disease were randomized to either PCI with a drug-eluting stent (DES) (88% biolimus) or CABG. They.

Improved Long-Term Survival for Diabetic Patients With Surgical Versus Interventional Revascularization Paul Kurlansky, MD, Morley Herbert, PhD, Syma.

The Clinical Significance and Management Implications of Chronic Total Occlusion Associated With Surgical Coronary Artery Revascularization Lorenzo Azzalini,

P2Y12 receptor inhibitor therapy for secondary prevention of patients with stable coronary artery disease. P2Y12 receptor inhibitor therapy for secondary.

Presentation transcript:

In Diabetics with Ischemic Heart Disease CABG revascularization is always superior? Dr. Paolo Ferrazzi

DN, male, 65 yr NIDDM, HT BMI 28 3 vessel disease What is the best OPTION? CLINICAL SCENARIO

Background Major developments in CABG – off-pump technique, less invasive approach, increased arterial revascularization and optimal perioperative care Major developments in PCI – improved technique, stent design, guide wires, anti-platelet therapy, and drug- eluting stents Important to reassess the respective values of the two revascularization

7812 patients Median FU 6 years 65%: 1 or 2 VD; all normal LV 1233 with DM HR for CABG vs PCI in DM 0.70; p= 0.01 Survival benefit of CABG increases with time Lancet 2009; 373: 1190–97

p=0,38 p=0,078 p<0,001

FREEDOM TRIAL:PATIENTS WITH DIABETES New England J. of Medicine, December 20, 2012; Vol. 367 No. 25

Survival benefit with two IMA grafts?

Bergamo experience 2012 Diabetic and non Diabetic Patients Patients n.139 LIMA (%)99% BIMA (%)43% A RAD (%)32% Perioperative mortality0.92

Bergamo experience Surgical options in diabetes LIMA Pedicled + RIMA skeletonized in situ LIMA + RIMA skeletonized in situ LIMA in situ + RIMA (Y grafted)

Actuarial survival unmatched diabetic pts Actuarial survival propensity score–matched diabetic pts Actuarial survival unmatched diabetic pts <65yr Actuarial survival unmatched diabetic pts ≥65yr p<0.001 P=0.006 P=0.014 Compared with SIMA grafting, BIMA grafting in propensity score–matched patients provides diabetics with enhanced survival without any increase in perioperative morbidity or mortality

Conclusions CABG seems to have better long-term results in complex multivessel diabetic patients Two mammary seems to be better than one Adding radial artery to revascularization strategy could further improve results The optimum revascularization strategy for each individual patient will depend on a careful consideration of the risks and benefits of each procedure in conjunction with the baseline risk profile

PCI CABG

SYNTAX Trial: top 15 Enrollers

P=0.001 P<0.001